Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
The appropriate strategy depends on age, medical history, symptoms, family history, medications, previous results, and whether a finding would change clinical decision-making
A recent Phase 2 randomised placebo-controlled trial tested efinopegdutide in people with obesity over a 26-week period, where participants were randomly assigned weekly treatment with either placebo, 5 mg, 7.4 mg, 10 mg efinopegdutide, or 3 mg liraglutide daily
Heart , 109 (17), 12941301
Keep it in a cool, dry area
One study of insured patients showed an 8.7% decline in surgical weight-loss procedures as GLP-1 use more than doubled from 2022 to 2023
Indian J Biochem Biophys
US$ 20.11
US$ 26.60
US$ 24.14
US$ 20.30
US$ 21.27
US$ 22.20
